IDYA News and Press, IDEAYA Biosciences Inc. From 11/07/23

2023-11-07 06:28:59 ET More on IDEAYA Biosciences IDEAYA's Triple Threat: Melanoma, Money, And Momentum Ideaya Biosciences: Eye Cancer Therapy Drives Gains - More Upside Ahead IDEAYA Biosciences down 9%, prices $125M offering IDEAYA announces proposed public ...

IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update PR Newswire Strong balance sheet of $511.1 million of cash, cash equivalents and marketable securities as of September 30, 2023 , supplemented by $134.7 million estim...

IDEAYA Biosciences Announces Plans for Investor R&D Day and Participation in Jefferies London Healthcare Conference IDEAYA Biosciences Announces Plans for Investor R&D Day and Participation in Jefferies London Healthcare Conference PR Newswire SOUTH SAN FRANCISCO...

2023-10-25 11:55:27 ET Ideaya Biosciences (NASDAQ: IDYA) stock is falling in Wednesday's trading. The company's share price was down 8.1% as of 11 a.m. ET, according to data from S&P Global Market Intelligence . Ideaya Biosciences published a press release after the mark...

2023-10-25 10:00:16 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in F...

2023-10-25 08:44:46 ET Losers: Sonnet BioTherapeutics Holdings ( SONN ) -35% announces pricing of $4.55 Million underwritten public offering . Alphatec Holdings ( ATEC ) -18% prices $150M stock offering at $10.50 per share. MAIA Biotechnology ( MAIA ...

2023-10-25 05:35:18 ET More on IDEAYA Biosciences IDEAYA's Triple Threat: Melanoma, Money, And Momentum Ideaya Biosciences: Eye Cancer Therapy Drives Gains - More Upside Ahead IDEAYA announces proposed public offering of common stock and pre-funded warrants F...

2023-10-24 17:37:02 ET Gainers: Vitru  ( VTRU ) +15% . Scholar Rock Holding  ( SRRK ) +7% . LianBio ( LIAN ) +5% . 908 Devices  ( MASS ) +5% . Microsoft Corporation ( MSFT ) +4% . Losers: Forbion European A...

2023-10-24 16:31:16 ET More on IDEAYA Biosciences IDEAYA's Triple Threat: Melanoma, Money, And Momentum Ideaya Biosciences: Eye Cancer Therapy Drives Gains - More Upside Ahead Tango Therapeutics stock plunges amid Amgen PRMT5 drug data (update) Ideaya Bio pic...

IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants PR Newswire SOUTH SAN FRANCISCO, Calif. , Oct. 24, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced that it intends to offer and sell up to $1...